Wixela Inhub is a medication used for the long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD) [1]. The price of Wixela Inhub can vary based on factors such as insurance coverage, pharmacy, and location [2].
How much does Wixela Inhub cost without insurance?
Without insurance, the retail price of Wixela Inhub can be substantial. A 30-day supply, which typically includes one inhaler, might range from approximately $500 to over $600 [2]. Prices can fluctuate, so it is advisable to check with local pharmacies for the most current pricing.
Can I get a Wixela Inhub coupon or discount?
Patients may be able to reduce the cost of Wixela Inhub through manufacturer coupons or discount programs. For eligible commercially insured patients, savings cards may be available that can lower out-of-pocket expenses. Information regarding these programs is often found on the drug manufacturer's website or through patient assistance program portals [2].
What is the Medicare or Medicaid coverage for Wixela Inhub?
Coverage for Wixela Inhub under Medicare and Medicaid plans can differ. Patients with Medicare Part D or Medicaid may have specific co-payment amounts that depend on their plan's formulary and benefit design [2]. It is recommended to verify coverage details with the specific Medicare or Medicaid plan provider.
How does Wixela Inhub's price compare to other COPD inhalers?
Wixela Inhub is a combination inhaler containing fluticasone furoate and vilanterol, which are commonly found in other COPD medications. The pricing of inhaled respiratory medications can vary significantly due to brand recognition, patent status, and the specific combination of active ingredients. For example, other combination inhalers for COPD may have different price points [1][2].
When does the patent for Wixela Inhub expire?
The patent expiration dates for pharmaceutical products like Wixela Inhub are crucial for the potential introduction of generic alternatives. DrugPatentWatch.com tracks and provides information on patent exclusivity for many medications [3]. Specific patent details and expiration timelines for Wixela Inhub can be found on specialized patent tracking websites.
What is the difference between Wixela Inhub and other fluticasone furoate/vilanterol inhalers?
Wixela Inhub is a specific branded product containing the active ingredients fluticasone furoate and vilanterol. Other inhalers may contain the same active ingredients but are marketed under different brand names or as generic versions once patent exclusivity has ended. The formulation, delivery device, and inactive ingredients can sometimes differ between these products [1].
What are the side effects of Wixela Inhub?
Common side effects of Wixela Inhub can include headache, nasopharyngitis (cold symptoms), oral candidiasis (thrush), hoarseness, and increased risk of pneumonia in patients with COPD [1]. It is important for patients to discuss potential side effects with their healthcare provider.
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/